Skip to content

CardioDerm

Active Private limited companyfounded 2019active for 7 yearsDieweg 250, 1180 UccleKBO/BCE: BE 0729.734.562

Lifetime

7 annual accounts with figures on one time axis
peak of €292,449 in 2022
€222,318▲ 3.7%
peak of €215,070 in 2022
€158,443▲ 4.4%
peak of €471,029 in 2023
€42,517▲ 24.8%
€176,454▼ 70.9%
Board3 names since 2019
1 director
Documentsfilings and deeds
30-06-202631 days before the deadline
2025micro format
Dividend €150,000Equity from €34,074 to €42,517Debts from €605,515 to €176,454Cash from €553,042 to €156,806

Key points

from the 2025 annual accounts

Equity

€42,517 from €471,029 in 2023

Equity fell by 91% in 2 years.

Debts

€176,454 81% of the balance sheet
Suppliers 3%Taxes and wages 22%Other 75%

Of this, €173,017 falls due within a year.

Filings

7 annual accounts 1 late
AprilJune31 JulyOctober202020222024

The 2019 accounts came 3 days late. The other six were filed on time.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 6,715 companies had the same profile as CardioDerm has now. Each dot stands for 17 companies, two years later.

95.8%
were still trading
2.2%
stopped another way
1.8%
went bankrupt
  • Micro
  • 5 to 10 years old
  • solvency 10 to 30%
  • a profit of 5% of the balance sheet or more

Another 0.1% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,762 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 6,715 companies, not a prediction for CardioDerm. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 01-07-2019
  • founderdeed of 05-07-2019
  • founderdeed of 05-07-2019
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0729734562
Resignation: (director) General meeting of 27-10-2023 · Gazette deed
Registered office moved within Uccle The registered office moved from Avenue de Fré 35A 1180 Uccle to Dieweg 250/252 1180 Uccle · General meeting of 30-11-2022 · Gazette deed
Incorporation Founders: and · 100 shares · Appointments: (director) and (director) · published on 05-07-2019 · Gazette deed
All 17 events

Comparable companies

same main activity, similar in size and age
Company
CardioDerm Uccle €218,972 €222,318 19.4% -
CABINET MEDICAL Christine DAUBRESSE Liège €217,917 €225,627 10.3% -
Dr CHULLIKAL Grez-Doiceau €205,689 €217,945 1.5% -
Cabinet Médical Coremans Lhoest Chaudfontaine €209,639 €213,904 61.0% -
GTPneumo La Bruyère €208,673 €230,720 3.0% -
Dr. Thomas Jardinet Mortsel €222,458 €229,015 0.9% -
DR. EVELINE THOMAERE Oostkamp €210,172 €228,423 1.4% -

These companies have the same main activity as CardioDerm: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €206,000 and €222,000, founded between 2019 and 2020.

Official details

Source: KBO
Status
Active since 03-07-2019Normal situation
Activity
Specialist medical practiceNACE 86220and 2 others
Establishment unit
2.291.270.3551180 Uccle, since 03-07-2019
Financial year end
31 December
Peppol
Reachable since 17-12-2025
Company details

Annual accounts 2025

≈ €410,000estimated
€218,972▼ 65.8%
Filing
Filed on 30-06-2026, 31 days before the end of the filing period
Financials

Insights on CardioDerm

CardioDerm files the micro format. That format states no turnover. The gross margin rose from €27,525 in 2019 to €222,318 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about CardioDerm

What is the company number of CardioDerm?
The company number of CardioDerm is 0729.734.562. The VAT number is the same number with BE in front: BE 0729.734.562.
Where is CardioDerm based?
The registered office is at Dieweg 250, 1180 Uccle.Company details
What does CardioDerm do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of CardioDerm?
CardioDerm is a private limited company (BV).
When was CardioDerm founded?
CardioDerm was founded on 03-07-2019.
Is CardioDerm still active?
Yes, CardioDerm is an active enterprise in the KBO register.
What is the turnover of CardioDerm?
The turnover in financial year 2025 is ≈ €410,000. This figure is estimated from the gross margin of €222,318 and 40 comparable companies (NACE 86220). It probably lies between €350,000 and €550,000.Financials
Is CardioDerm profitable?
In financial year 2025, CardioDerm made a profit of €158,443.
Where can I find the annual accounts of CardioDerm?
CardioDerm filed 7 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of CardioDerm due?
CardioDerm must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.